3D Ballistocardiography in Microgravity

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02517112

Acronym

B3D

Enrollment

Registered

2015-08-06

Start date

2011-12-31

Completion date

Unknown

Last updated

2015-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

volunteers

Brief summary

3-D Ballistocardiography (BCG) recording was performed in microgravity during the Spacelab D2 missions on a single astronaut. The results from this experiment have been published in the literature: the influence of respiration have been demonstrated and the signal processing methodology for the reconstruction of the displacement in one cardiac cycle have been developed. A 3D-BCG sensor has been developed and a collaboration to perform a sustained microgravity experiment onboard the Russian segment of ISS has been initiated. To be integrated in the PNEUMOCARD device, this new sensor needs to be tested in microgravity before implemented on ISS. The aim of the present parabolic flight study is to serve as a feasibility demonstrator and test bed in order to evaluate the feasibility of 3D-BCG in sustained microgravity and to test whether the sensitivity of the developed 3D-BCG sensor is appropriate

Interventions

OTHERParabolic flight

OTHERCardiovascular parameters measurements

with Ballistocardiography (BCG), electric cardiography (ECG), impedance cardiography (ICG) and echocardiography

DEVICE3D-BCG sensor

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy volunteers (men or women) * Aged from 18 to 65 * Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC) * Who accepted to take part in the study * Who have given their written stated consent * Whose 4 chamber view of the heart during a breath hold is easy to get during a routine cardiac echocardiography (M-Mode - apical view). * Who has passed a medical examination similar to a standard aviation medical examination for private pilot aptitude (JAR FCL3 Class 2 medical examination). There will be no additional test performed for subject selection.

Exclusion criteria

* Person who took part in a previous biomedical research protocol, of which exclusion period is not terminated * Difficulty to obtain a clear echocardiography. * Pregnant women

Design outcomes

Primary

Measure	Time frame	Description
Heart rate	baseline	evaluated by BCG, ECG, ICG and echocardiography during the free-floating protocol
stroke volume	baseline	evaluated by BCG, ECG, ICG and echocardiography during the free-floating protocol
ejection fraction	baseline	evaluated by BCG, ECG, ICG and echocardiography during the free-floating protocol

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026